In patients with colitis, the amount of plasma Alb is decreased because of the chronic inflammation in the intestinal tract, and the antioxidative capacity of Alb is also weakened due to the oxidative modification [22,[31], [32], [33]]. The gene discussed is ALB; the disease is colitis.